Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

NCT00359762 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1029

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide
DRUG: glimepiride

Sponsor

AstraZeneca

Collaborators

[object Object]